PathogenAR

Pathogens in AR from NIAID

Published by: NIAID
Downloads
Revenue

Description

PathogenAR is an Augmented Reality application from the National Institute for Allergy and Infectious Diseases (NIAID). Explore interactive stories about pathogens and pathogenic disease using touch gestures or a Merge Cube Device.

Screenshots

PathogenAR FAQ

  • Is PathogenAR free?

    Yes, PathogenAR is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is PathogenAR legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does PathogenAR cost?

    PathogenAR is free.

  • What is PathogenAR revenue?

    To get estimated revenue of PathogenAR app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Switzerland yet.
Ratings History

PathogenAR Reviews

No Reviews in Switzerland
App doesn't have any reviews in Switzerland yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

PathogenAR Competitors

Name
Brainapse
Explore the human brain in AR!
Malaria Invasion™
Turning Genes into Medicine
An Educational AR Experience
ID Podcasts
N/A
Schol-AR
Cell Toy
360ed’s Elements AR
Moderate to Severe Asthma AR
GIDEON platform
Infectious Diseases Consultant

PathogenAR Installs

Last 30 days

PathogenAR Revenue

Last 30 days

PathogenAR Revenue and Downloads

Gain valuable insights into PathogenAR performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.